Intranasal bupropion abuse: Case report

American Journal on Addictions

Volumn 22, Issue 2, 2013, Pages 180-

  Yoon, Gihyun ^a,b   Westermeyer, Joseph ^a,b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUPRENORPHINE PLUS NALOXONE; ANTIDEPRESSANT AGENT;

ADULT; ALCOHOLISM; CASE REPORT; COCAINE DEPENDENCE; DECREASED APPETITE; DEPRESSION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG MISUSE; EPISTAXIS; HUMAN; LETTER; MALE; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PARANOIA; PARESTHESIA; PRISONER; PSYCHOPHARMACOTHERAPY; ADDICTION; INTRANASAL DRUG ADMINISTRATION; PSYCHOLOGY;

ADMINISTRATION, INTRANASAL; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ADDICTIVE; BUPROPION; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS;

EID: 84874029667     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.00329.x     Document Type: Letter

References (7)

1. Welsh CJ, Doyon S., Seizure induced by insufflation of bupropion. N Engl J Med. 2002; 347: 951.
2. Khurshid KA, Decker DH., Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol. 2004; 14: 157-158.
3. Hill S, Sikand H, Lee J., A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007; 9: 67-69.
4. Langguth B, Hajak G, Landgrebe M, et al. Abuse potential of bupropion nasal insufflation: A case report. J Clin Psychopharmacol. 2009; 29: 618-619.
5. Kim D, Steinhart B., Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. Can J Emerg Med. 2010; 12: 158-161.
6. de la Garza R, Johanson CE., Discriminative stimulus properties of intragastrically administered D -amphetamine and pentobarbital in rhesus monkeys. J Pharmacol Exp Ther. 1987; 243: 955-962.
7. Rush CR, Kollins SH, Pazzaglia PJ., Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in D -amphetamine-trained humans. Exp Clin Psychopharmacol. 1998; 6: 32-44.